Ãëàâíàÿ    Ex Libris    Êíèãè    Æóðíàëû    Ñòàòüè    Ñåðèè    Êàòàëîã    Wanted    Çàãðóçêà    ÕóäËèò    Ñïðàâêà    Ïîèñê ïî èíäåêñàì    Ïîèñê    Ôîðóì   
blank
Àâòîðèçàöèÿ

       
blank
Ïîèñê ïî óêàçàòåëÿì

blank
blank
blank
Êðàñîòà
blank
Gomperts B.D., Tatham P.E.R., Kramer I.M. — Signal Transduction
Gomperts B.D., Tatham P.E.R., Kramer I.M. — Signal Transduction



Îáñóäèòå êíèãó íà íàó÷íîì ôîðóìå



Íàøëè îïå÷àòêó?
Âûäåëèòå åå ìûøêîé è íàæìèòå Ctrl+Enter


Íàçâàíèå: Signal Transduction

Àâòîðû: Gomperts B.D., Tatham P.E.R., Kramer I.M.

Àííîòàöèÿ:

Signal Transduction is a text reference on cellular signalling processes. Starting with the basics, it explains how cells respond to external cues (hormones, cytokines, neurotransmitters, adhesion molecules, extracellular matrix, etc), and shows how these inputs are integrated and co-ordinated. The first half of the book provides the conceptual framework, explaining the formation and action of second messengers, particulary cyclic nucleotides and calcium, and the mediation of signal pathways by GTP-binding proteins. The remaining chapters deal with the formation of complex signalling cascades employed by cytokines and adhesion molecules, starting at the membrane and ending in the nucleus, there to regulate gene transcription. In this context, growth is an important potential outcome and this has relevance to the cellular transformations that underlie cancer. The book ends with a description at the molecular level of how signalling proteins interact with their environment and with each other through their structural domains. Each main topic is introduced with a historical essay, detailing the sources key observations and experiments that set the scence for recent and current work.


ßçûê: en

Ðóáðèêà: Òåõíîëîãèÿ/

Ñòàòóñ ïðåäìåòíîãî óêàçàòåëÿ: Ãîòîâ óêàçàòåëü ñ íîìåðàìè ñòðàíèö

ed2k: ed2k stats

Ãîä èçäàíèÿ: 2002

Êîëè÷åñòâî ñòðàíèö: 424

Äîáàâëåíà â êàòàëîã: 21.12.2005

Îïåðàöèè: Ïîëîæèòü íà ïîëêó | Ñêîïèðîâàòü ññûëêó äëÿ ôîðóìà | Ñêîïèðîâàòü ID
blank
Ïðåäìåòíûé óêàçàòåëü
PI 3-kinase (phosphatidylinositol 3-kinase)      92 121 262 276 300—305 300
PI 3-kinase family      301—303 302
PI 3-kinase family, class I kinases      301—303
PI 3-kinase family, class II kinases      303
PI 3-kinase family, class III kinases      303
PI 3-kinase, activation by insulin receptor      306 306
PI 3-kinase, activation pathways      304 304
PI 3-kinase, glucose transport activation      307
PI 3-kinase, inhibition studies      303
PI 3-kinase, lipid product measurements      303
PI 3-kinase, protein synthesis regulation      307—308 309
PI(4, 5)P2 (phosphatidylinositol 4, 5-bisphosphate)      42 119 120 120 121 123 154 262 300 303
PI-3, 4, 5-P3      121 204 205 300 301 303
PI-3, 4, 5-P3, dephosphorylation      382—383
PI-3, 4, 5-P3, protein kinase B activation      305 305
PI-3, 4-P2      204
PICKs      205
Pilocarpine      15
Pindolol      37 60
PIP2—see “PI(4, 5)P2 (phosphatidylinositol      4 5-
Pirenzepine      40
PKA (protein kinase A)      31 84 85 175 192—193 406—407 406
PKA, activation by cyclic AMP      192—193 193
PKA, ERK activation      196—197
PKA, glycogen metabolism      386
PKA, phosphorylation      49 185 191 193
PKA, phosphorylation, adenylyl cyclase regulation      112 115 191
PKA, transcription regulation      194 196
PKB (protein kinase B)      300 304—305 310 311 326 352
PKB, insulin activation      307
PKB, PDGF activation      307
PKB, PI(3, 4, 5) P3 activation      305 305
PKB, subtypes      304 305
PKC (protein kinase C)      31 198—204
PKC (protein kinase C) family      199—201 199 200
PKC, activation      120 179 199 202—204 203 261 407
PKC, activation, DAG (diacylglycerol)      198 199 201 203 203 204—205 204
PKC, anchoring proteins      205—206 206
PKC, cell transformation      208—212
PKC, inflammation      212—217
PKC, inflammation, integrin activation      352
PKC, inflammation, respiratory burst regulation      215—217 216
PKC, isoforms      199 799
PKC, isoforms, differential localization      205
PKC, isoforms, overexpression in transformed cells      211—212
PKC, phosphorylation      49 198—199
PKC, phosphorylation, adenylyl cyclase regulation      112 115
PKC, pseudosubstrates      202
PKC, SRE activation      210 211
PKC, structural domains      201—202 201
PKC, tRE activation      208—209 209 210
PLA2 (phospholipase A2)      84 121
Plakoglobin      322
Plasma membrane      2
Plasma membrane, $Na^+fCa^{2+}$ exchangers      149
Plasma membrane, lipid raft hypothesis (microdomains)      289—290
Plasma membrane, voltage-operated $Ca^{2+}$ channels (VOCCs)      157
Platelet derived growth factor      see “PDGF”
Platelets      23
Platelets, thrombin activation      58
PLC (phospholipase C)      42 84 119—125
PLC, domain organization      121 123 124
PLC, intracellular $Ca^{2+}$ mobilization      153 154
PLC, IP3 formation      121
PLC, isoenzymes      121 123
PLC, phototransduction mechanisms      130
PLC, regulation      123—125
PLD (phospholipase D)      121 161
Pleckstrin homology domains      see “PH domains”
PLK1 (polo-like protein kinase)      243
PMA (phorbol myristate acetate; TPA)      199 199 208 212
Pocket-proteins      235 242
Polo-like protein kinase      see “PLK1”
Polyoma virus      257
POMC (pro-opiomelanocortin)      4
PP1 (protein phosphatase-1)      195 196 384 384
PP1, glycogen metabolism regulation      386—388
PP1G (protein phosphatase-1G)      307 384 386 387
PP2A      384 387
PP2B      see “Calcineurin”
PP2C      384
PPM serine-threonine phosphatases      385 385
PPP serine-threonine phosphatases      385 385
Practolol      36
Prenylation, G-protein subunit post-translational modification      82 83
Pro-opiomelanocortin      see “POMC”
Progesterone      20 24 25 61
Prolactin      4
Prolactin receptors      284
Proliferating cell nuclear antigen      see “PCNA”
Propranolol      36 37 55 60
Prostaglandin E2      23 24 58
Prostaglandins      20
Prostaglandins, adenylyl cyclase activation      62
Proteasome      246
Protein domains      393—409
Protein domains, $Ca^{2+}$ binding polypeptides      401—403
Protein domains, functions      394—395
Protein domains, identification      394
Protein domains, oligopeptide motif-binding      395—398
Protein domains, protein kinases      403—409
Protein domains, protein/lipid-binding      398—399 400 401
Protein domains, structurally conserved      393—395 393
Protein kinase A      see “PKA”
Protein kinase B      see “PKB”
Protein kinase C      see “PKC”
Protein kinases      189
Protein kinases, domain organization      403—409
Protein kinases, domain organization, kinase activity      404—407
Protein kinases, domain organization, structure      403—404 404
Protein kinases, regulation by phosphorylation      407
Protein phosphatase 1      see “PP1”
Protein phosphatase 1G      see “PP1G”
Protein serinefthreonine kinases      359—370
Protein synthesis regulation, ERK (extracellular signal regulated protein kinase)      272—273 273
Protein synthesis regulation, PI 3-kinase      307—308 309
Protein tyrosine kinases      see “PTKs”
Protein tyrosine phosphatases      see “PTPs”
Proteinase activated receptors      see “PAR receptors”
Protohormones      2-4
PTB/PID domains      263 306 396 397
PTEN      249 381—383 383
PTH (parathyroid hormone)      20
PTKs (protein tyrosine kinases)      190
PTKs, $PLC\gamma$ activation      124 263
PTKs, $PLC\gamma$ activation, signal transduction pathway      265
PTKs, non-receptor      283—295
PTKs, receptor      257—279
PTPC      340
PTPs (protein tyrosine phosphatases)      373—383
PTPs, cytosolic      375—376
PTPs, domain organization      375
PTPs, role in signal transduction      376—378
PTPs, transmembrane receptor-like      374—375
Quin2      151 151
Rab      86
RAc      216 310 328 352
Rac2      215
racks      205
Raclopride      61
RAF      91 92 210
Raf-1      210
Raf-1 kinase      271
Ran      86
RAP1      80 197 198 798
Rapamycin      308
RAS      81 86 197 210 235 275 329 352
Ras proteins      85—92
Ras proteins, functions      90—91 90
Ras proteins, post-translational lipid modification      86 86 90
Ras proteins, structure      87—90 87 88 89
Ras proteins, subfamilies      86—87
Ras, cancer-promoting mutations      91 250 251 293
Ras, functions      91—92 92
Ras, GEFs      95
Ras, GTPase activation mechanism      93—95 94
Ras, regulation pathway      269—270
Ras, signalling pathway      266
Ras-GAP $(p120^{GAP})$      92—93 270
Ras-GAP, domain organization      93 93
Ras-MAP kinase pathway      270—271 270
Rb protein      242—243 249 250
Rb110      235 236 241
Receptors      14—16 33—66
Receptors, activation, ligand binding      58—59
Receptors, activation, without stimulating ligand      59—60
Receptors, dimerization      61—62
Receptors, down-regulation      30—31
Receptors, effector enzymes      62—63 63 64
Receptors, effector enzymes, experimental approaches      63—65 65
Receptors, evolutionary aspects      4
Receptors, G-protein modulation of affinity      76 77
Receptors, ion channel-linked      42—51 158
Receptors, ligand interactions      58—62
Receptors, ligand interactions, competitive binding      36 38
Receptors, ligand interactions, modulation by G-proteins      76 77
Receptors, metabotropic      42 56—57
Receptors, overexpression      60—61
Receptors, spare      30
Receptors, total number (Rtot)      27 28 31
Receptors, tyrosine kinase-linked      see “Tyrosine kinase-linked receptors”
Recoverin      179—180
Regulators of G-protein signalling      see “RGS proteins”
Renin      36
Respiratory burst      213—215 215 317 352
Respiratory burst, PKC regulation      215—217 276
Restriction point      234
retina      130 131
Retinoblastoma      242
RGD motifs      318
RGS proteins (regulator of G-protein signalling)      75—76
RGS-12      76
Rho      86 300 352
Rho family      328 330
RhoA      328 330 337 352
Rhodopsin      51 54 61 96 127 130 180
Rhodopsin kinase      84 139
Rhodopsin, membrane-spanning sequences/topology      51—52 52 53
Rhodopsin, photo-excitation      134 137 738
Rhodopsin, rod cell organization      131 732
RhoGAP      94
RhoGEF      80 328
RIP      350
Rod cells      130—135 732
RSV (Rous sarcoma virus)      226 258
RyR (ryanodine receptor)      154—157 155 159 165 166 182 184
S phase      233 233 236—237
S49cyc lymphoma cells, $cyc^-$subline      77 78
Salbutamol      36 37
SAPK (stress activated protein kinase)      274
SARA      369
Sarcolemma      182
Sarcoma      226
Sarcoplasmic reticulum      see “SR”
Sarin      49
Scatter factor      328
SCF complex      246
Schizophrenia      61
Second (intracellular) messengers      25
Secretin      9 19 20
Selectins      323 323
Sem-5      268
Senescent cells      234
Serine esterase inhibitors      39
Serine esterases      58
Serine-threonine kinases      359—370
Serine-threonine phosphatases      383—390
Serine-threonine phosphatases, classification      385 385
Serotonin (5-hydroxytryptamine)      4 20 23
Serotonin (5-hydroxytryptamine) receptors      42 50
Serum response element      see “SRE”
Serum response factor      ee “SRF”
Sev (sevenless)      266 267
Sf9 insect cells, adrenergic receptor/adenylyl cyclase system      59 98—99 99
SH2 domain      124 260 262 263 264 268 269 286 287 288 294 301 326 376 395—396 395 408 409
SH3 domain      124 216 262 268 269 294 301 396 398 398 408
Shc      329
SHP-1 (Src homology phosphatase-1)      376 380—381
SHP-2 (Src homology phosphatase-2)      376 377—378 379
Sialyl LewisX      323 354
SIF (Sis-inducible factor)      276
Signal transducer and activator of transcription      see “STATs”
Signal transmission      62—65
Signal transmission, 7TM receptors      65—66
Signal transmission, adenylyl cyclase activation      62—63 63 64
Signal transmission, adenylyl cyclase activation, experimental approaches      63—65 65
Simian sarcoma virus      see “v-Sis”
Simian virus 40      see “SV40”
SIS      249
Sis-inducible factor      see “SIF”
Skeletal muscle, $Ca^{2+}$ signalling      165—166
Skeletal muscle, $Ca^{2+}$ signalling, contraction initiation      182—184
Skpl      246
SLP76      287
Smad1      166
Smad2      366 367 370
Smad3      366
Smad4      366 368 370
Smad5      366
Smad6      368
Smad7      368
Smad8      366
SMADs      362 365—370 366
Smads, antagonistic      368 368
Smads, receptor-regulated      366 367
Smads, transcription regulation      367 369—370
Smads, tumour suppression      370
Smooth muscle contraction      184
SNAP25      181
SNARE complex      181
SOCs (store-operated channels)      158—159 759
Somatomedin 1 (IGF1; insulin-like growth factor 1)      20 242 249
Somatomedin 2 (IGF2; insulin-like growth factor 2)      20
Somatostatin      19 194
Somatostatin receptor      99
Somatotropin (GH; growth hormone)      20 119
Sos (son of sevenless)      267 268 269 277
Spare receptors      30
Sphingomyelin      161 162
Sphingosine      161
Sphingosine kinase      161
Spindle (metaphase) checkpoint      234 244—245 245
Spore formation (starvation response)      95 108
SR (sarcoplasmic reticulum)      154 157 166 182
SRC      84 257 294 329
Src family kinases      294—295
Src family kinases, activation      295 295 407
Src family kinases, suppression      295
Src homology domains      262õ265 268
Src homology phosphatases      see “SHP-1“ “SHP-2”
Src, regulatory domains      408 409 408
SRE (serum response element)      92 209 210 211 271
SRF (serum response factor)      209
St Vitus dance      12 73
Starvation, cyclic AMP synthesis response      107 108
Starvation, yeast spore formation      95
STAT1      291
STAT2      291
STAT3      80
STAT5      381
1 2 3 4 5
blank
Ðåêëàìà
blank
blank
HR
@Mail.ru
       © Ýëåêòðîííàÿ áèáëèîòåêà ïîïå÷èòåëüñêîãî ñîâåòà ìåõìàòà ÌÃÓ, 2004-2024
Ýëåêòðîííàÿ áèáëèîòåêà ìåõìàòà ÌÃÓ | Valid HTML 4.01! | Valid CSS! Î ïðîåêòå